$OCGN #OCUGEN I only see RS making sense if we have very big catalysts to happen in a really short time, either way it ends up being speculative so dont know how to think about it but lets hope Shankar will take care with everyone that helped his business stay active and running
@B1llyTh2K3d@drsmusunuri@Ocugen Hey Billy, a question here, isn't there the possibility of they wanting the RS to attract institucional investment? Also for us isn't it good in a case of a squeeze? Less float?
If the MCap stays the same I don't really see the issue here,still think this is a future 50B company
Great move for $AMD on this annoucement, if $NVIDIA beats earnings will give a good message for investors that the chips are being sold at good pace, and amd will follow aswell. The fear on AI will gradually disappear and everyone will accept it and the $$$ it will move
@benitoz@michaeljburry and 5000Tflops for Blackwell. Doing math, dividing 5000tflops per 19tflops gives a jump os 263x in 8 years, not a thousand. And the graph is like that to make look a bigger jump from hopper to blackwell as well. Probably that's why michael doesn't like it that much.
@benitoz@michaeljburry I get the point, but Jensen is pumping himself out here. He shows the graph for hopper at FP8 and Blackwell at FP4. It's all made on purpose to make it look bigger that what it is. So, if all of the chips we're presented on FP16 that would give around 2000Tflops FP16 for Hopper +
We are now enrolling patients as young as 3 in our OCU410ST Phase 2/3 GARDian3 clinical trial for #Stargardtdisease. Phase 1 data shows 100% stabilization or improvement in treated eyes and 48.2% slower lesion growth.
Learn more: [email protected]#OCU410ST#Ocugen
@B1llyTh2K3d Hey billy, just to let you know that maybe nvax got its luck, heard on portuguese news that the portuguese health care system approved nxav. Im still waiting on covaxin, got 0 vax for now